JP2025500824A5 - - Google Patents

Info

Publication number
JP2025500824A5
JP2025500824A5 JP2024534724A JP2024534724A JP2025500824A5 JP 2025500824 A5 JP2025500824 A5 JP 2025500824A5 JP 2024534724 A JP2024534724 A JP 2024534724A JP 2024534724 A JP2024534724 A JP 2024534724A JP 2025500824 A5 JP2025500824 A5 JP 2025500824A5
Authority
JP
Japan
Prior art keywords
cells
optionally substituted
saturated
branched
independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025500824A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/053193 external-priority patent/WO2023121971A1/en
Publication of JP2025500824A publication Critical patent/JP2025500824A/ja
Publication of JP2025500824A5 publication Critical patent/JP2025500824A5/ja
Pending legal-status Critical Current

Links

JP2024534724A 2021-12-20 2022-12-16 四価脂質化合物を含むナノ材料 Pending JP2025500824A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163291593P 2021-12-20 2021-12-20
US63/291,593 2021-12-20
US202263354640P 2022-06-22 2022-06-22
US63/354,640 2022-06-22
PCT/US2022/053193 WO2023121971A1 (en) 2021-12-20 2022-12-16 Nanomaterials comprising tetravalent lipid compounds

Publications (2)

Publication Number Publication Date
JP2025500824A JP2025500824A (ja) 2025-01-15
JP2025500824A5 true JP2025500824A5 (cg-RX-API-DMAC10.html) 2025-12-19

Family

ID=85157420

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534724A Pending JP2025500824A (ja) 2021-12-20 2022-12-16 四価脂質化合物を含むナノ材料

Country Status (6)

Country Link
US (1) US20240358841A1 (cg-RX-API-DMAC10.html)
EP (1) EP4452926A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025500824A (cg-RX-API-DMAC10.html)
AU (1) AU2022421708A1 (cg-RX-API-DMAC10.html)
CA (1) CA3241503A1 (cg-RX-API-DMAC10.html)
WO (1) WO2023121971A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7600208B2 (ja) 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用
CN115175894B (zh) 2020-01-09 2024-09-06 盖德治疗有限责任公司 纳米材料
CN116761888A (zh) 2021-01-20 2023-09-15 比姆医疗股份有限公司 纳米材料
EP4281080A4 (en) 2021-01-20 2025-09-24 Beam Therapeutics Inc NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT
US20260234115A1 (en) * 2023-05-30 2026-08-13 Liberate Bio, Inc. Lipid compounds, compositions, and uses thereof
KR20260094503A (ko) * 2023-09-13 2026-06-22 테세라 테라퓨틱스, 인크. 치료용 페이로드를 세포에 전달하기 위한 지질 나노입자
WO2025193861A2 (en) * 2024-03-12 2025-09-18 Tessera Therapeutics, Inc. Lipid nanoparticles for delivery of therapeutic payloads to cells
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026134325A1 (ja) * 2024-12-20 2026-06-25 武田薬品工業株式会社 カチオン性脂質

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1021549A2 (en) 1997-09-19 2000-07-26 Sequitur, Inc. SENSE mRNA THERAPY
EP1164125A4 (en) * 1999-11-08 2005-05-04 Daicel Chem ADAMANTANE DERIVATIVES AND PROCESS FOR PREPARING
WO2003101952A2 (en) * 2002-05-31 2003-12-11 The Regents Of The University Of California Polyamine-mediated transfection
JP2005181734A (ja) * 2003-12-19 2005-07-07 Fuji Photo Film Co Ltd 画像記録材料
EP2279254B1 (en) 2008-04-15 2017-07-05 Protiva Biotherapeutics Inc. Novel lipid formulations for nucleic acid delivery
US20150166984A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting alpha-antitrypsin point mutations
US10059655B2 (en) * 2013-12-19 2018-08-28 Novartis Ag Lipids and lipid compositions for the delivery of active agents
PL3178807T3 (pl) * 2014-08-07 2020-08-24 Takeda Pharmaceutical Company Limited Lipid kationowy
HRP20220156T1 (hr) 2015-09-17 2022-04-15 Modernatx, Inc. Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava
WO2017070632A2 (en) 2015-10-23 2017-04-27 President And Fellows Of Harvard College Nucleobase editors and uses thereof
WO2018027078A1 (en) 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
CN111542338B (zh) * 2017-12-27 2024-06-18 武田药品工业株式会社 含核酸脂质纳米粒子及其用途
WO2020032184A1 (ja) * 2018-08-10 2020-02-13 武田薬品工業株式会社 カチオン性脂質
JP7436990B2 (ja) * 2018-08-10 2024-02-22 国立大学法人京都大学 カチオン性脂質を用いた心筋細胞へのトランスフェクション方法
ES3025233T3 (en) * 2019-01-24 2025-06-06 Agfa Nv Radiation curable inkjet inks for interior decoration
EP3924479A4 (en) 2019-02-13 2023-01-25 Beam Therapeutics, Inc. ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE
JP7600208B2 (ja) * 2019-07-29 2024-12-16 ジョージア テック リサーチ コーポレイション 拘束された脂質を含むナノ材料およびその使用

Similar Documents

Publication Publication Date Title
JP2025501731A5 (cg-RX-API-DMAC10.html)
JP2024505449A5 (cg-RX-API-DMAC10.html)
JP2024502948A5 (cg-RX-API-DMAC10.html)
JP2024503441A5 (cg-RX-API-DMAC10.html)
AU2019277361B2 (en) Messenger RNA vaccines and uses thereof
JP2024502954A5 (cg-RX-API-DMAC10.html)
US11980595B2 (en) Preventive or therapeutic agent and pharmaceutical composition for inflammatory diseases or bone diseases
EA033966B1 (ru) Стереохимически обогащенные композиции для доставки нуклеиновых кислот
EP4282420A1 (en) Anti-viral agent
JP2009533457A (ja) C−ニトロソから誘導されるニトロキシル供与体
CN117897162A (zh) 治疗性核酸及其使用方法
TWI910300B (zh) 預防或治療egfr功能異常相關的副作用的方法
JP2024503976A5 (cg-RX-API-DMAC10.html)
JP2001520656A (ja) 抗腫瘍剤としてのホルボールエステル類
WO2023023351A1 (en) Deuterated analogs and derivatives of 4-bromo-2,5-dimethoxyphenethylamine and uses thereof
WO2024183821A1 (zh) 可离子化脂质分子及其制备方法和应用
CN117430541B (zh) 用于向细胞递送的化合物及其组合物
CN120360978A (zh) 化合物用于治疗射血分数保留的心衰的用途
WO2021129890A1 (zh) 阻断微生物感染、降低胆固醇、防治相关肿瘤的药物及其应用
WO2024078614A1 (zh) 用于递送生物活性成分的氨基脂质化合物和脂质纳米颗粒
CN111803482B (zh) 鹿茸单体在制备抑制乳腺肿瘤骨转移的药物中的应用及药物
FR3110836A1 (fr) Utilisation de NMN pour réduire l’immunodépression et l’immunosénescence
JP2021155397A (ja) ベータコロナウイルス感染を防止する組成物
JP7290223B2 (ja) IL-1β阻害薬
KR20240167649A (ko) 아미노 지질 화합물, 이의 제조 방법, 이의 조성물 및 이의 용도